A Young Biotech ETF With Plenty of Potential
September 06, 2019 at 11:09 AM EDT
The Global X Genomics & Biotechnology ETF (Nasdaq: GNOM) debuted earlier this year, making it one of the newest additions to the biotech ETFs fray, but despite its rookie status, GNOM is a fund with ample potential for risk-tolerant, long-term investors. GNOM tracks the Solactive Genomics Index...